4 The Impact of Age-Specific Risks of Lymphoma on the Decision to Use Combination Therapy With Infliximab and Azathioprine Versus Infliximab Alone: A Markov Model

Journal article

Peer reviewed

Frank I. Scott, Ravy K. Vajravelu, Meenakshi Bewtra, Ronac Mamtani, David S. Goldberg and James D. Lewis

Gastroenterology (New York, N.Y. 1943), Vol.146(5), pp.S-1-S-2

2014-05

Metrics

2 Record Views

Title: 4 The Impact of Age-Specific Risks of Lymphoma on the Decision to Use Combination Therapy With Infliximab and Azathioprine Versus Infliximab Alone: A Markov Model
Creators: Frank I. Scott
Ravy K. Vajravelu
Meenakshi Bewtra
Ronac Mamtani
David S. Goldberg
James D. Lewis
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.146(5), pp.S-1-S-2
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031714263902976